ClinicalTrials.gg
Enrolling by invitationNCT07042815Updated Nov 20, 2026

Long-term Follow-up for Epidural Stimulation in SCI

An interventional study of Epidural Stimulation Programs in SCI - Spinal Cord Injury, sponsored by Kessler Foundation. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Kessler Foundation · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jan 2025, registered Apr 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
91
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 41 studies in Spinal Cord Injuries by Kessler Foundation — 22 open to participants now, 22 under way, none of them phase 3. Spinal Cord Injuries · Kessler Foundation.

Planned enrollment
5th of 38
91 · median 26
Started
2025
with 3 others
No phase
25 of 41
18 open now
Primary completion
2028-07
later than 14 of 21 live
Registered
35th of 41
by date

Among the 41 studies in Spinal Cord Injuries by Kessler Foundation, this one is the 5th largest by planned enrollment of the 38 interventional ones that give a count, is one of 4 that started in 2025, is one of 25 with no phase, reaches primary completion later than 14 of the 21 other live ones, and was the 35th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

22 of the 41 studies in Spinal Cord Injuries by Kessler Foundation are open now, in 1 country. Recruiting first, the newest first:

16 more — sign in →

By country, each count listing its studies:

All 22 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 41 studies in Spinal Cord Injuries by Kessler Foundation, or all of them as a file.
02

Study summary

The goal of this study is to understand long-term effects of spinal cord stimulation in individuals who have a spinal cord injury. The main aims are to:

  1. provide support for those with epidural stimulators who choose to continue stimulating because they deemed them to improve their quality of life
  2. provide additional sites for follow-up so that the financial burden can be minimized for the research participants to travel
  3. collect long-term safety data; and
  4. when feasible collect data to understand the sustainability of outcomes.

Participants will:

  • receive stimulation programs and software for the activities and/or functions completed in the previous study and demonstrate to the research staff that I can conduct them without their help to use at home
  • continue using the stimulation programs at home as directed by the research staff
  • return to Kessler Foundation for a follow-up visit (approx. 2 hours) with assessments at 6 months, 1 year, and once a year after enrolled in the follow-up study last until either the device is turned off, removed or the device is commercially approved.
Read the detailed description

SCI participants who previously had an epidural stimulation device and completed the initial study can continue using stimulation programs at home once they have proven to study staff that they can use the programs and device on their own. This follow-up study will give insight into potential benefits from long-term use of spinal stimulation.

In-person follow-up visits (approx. 2 hours long) will be requested at 6-months, 1 year, and once a year until the device is removed or approved for commercial use. If the participant can't come to Kessler for an in-person visit, a remote tele-health visit will be arranged. Visits include:

  • medical history since the last visit will be collected
  • a physical exam
  • assessments completed during the study previously enrolled in including:

    • Testing of muscle and limb responses to stimulation
    • Assessment of sitting, standing, and stepping function
    • Bladder and bowel function tests
    • Spasticity assessments
    • Blood pressure monitoring
    • Questionnaires
    • MRI
    • TMS
    • DXA
  • The study physician will contribute to decisions about which of these assessments are most appropriate to perform at a particular visit
  • The investigators will review stimulation logs
  • The investigator will review results of the assessments and discuss continuing in the follow up study.
03

Conditions studied

  • SCI - Spinal Cord Injury

Keywords

  • spinal stimulation
  • epidural
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • at least 18 years of age
  • have a spinal cord injury that is not getting worse
  • received a neurostimulator and electrode array as part of a previous study
  • choose to continue epidural stimulation in the home and community
  • have completed a previous IRB approved epidural stimulation study at a participating research site

Exclusion criteria

Exclusion Criteria:

  • heart, lung, bladder, kidney or other untreated medical disorder unrelated to SCI
  • choose not to use the epidural stimulation as recommended by the investigators
  • withdrawn from the main epidural stimulation study or made the choice to remove the stimulator/return the controller to the site
  • new surgeries, diagnoses, or other changes in status since completion of main epidural study that may affect the ability to complete assessments
  • Unable to undergo an MRI
  • Conditions that may make me ineligible for transcranial magnetic stimulation (a kind of brain stimulation through the skin)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
91 participants (estimated)

Study arms

  • Experimental
    Home Use and Follow-Up Visit Group

    Participants will be cleared by study staff for home-use of the stimulation programs they received in the previous study. Participants will then follow and log the programs according to study staff recommendations.

    Device: Epidural Stimulation Programs

Interventions

  • DeviceEpidural Stimulation Programs

    Epidural stimulations will accompany stimulation programs that have been established during research visits in the prior study and have been recommended by the clinical research team for use in the home and community. Stimulation programs will be given for activities (such as standing or walking) and/or responses that were completed in the previous study. This will be continued until the device is removed or approved for commercial use.

06

What researchers measure

Primary outcomes

  1. Motor Control Assessments with stimulation

    Participants will receive epidural stimulation and motor tasks based on their prior study participations' assessments and programming. During this stimulation, participants will be given motor tasks that may involve sitting, standing, stepping, and movement of their extremities. Electrodes will be placed over the specific muscles measured in that motor task. Data from those electrode readings will be transferred to numerical data. Plots from that numerical data will be created by identifying amplitude against stimulation intensity and threshold intensity, rate of recruitment, and plateau intensity per muscle using customized MATLAB software and then compared to results in the participants' prior training study.

    Time frame: On average, 1 hour each visit completed 6 months, 1 year, and yearly

  2. Bladder Function Assessment

    This assessment will only be performed in the participants who previously completed the locomotor, bladder and bowel intervention study (R-1230-23) The bladder function assessment includes a urinalysis and bladder pressure test. The bladder pressure test involves emptying of the bladder and refilling with saline with a catheter that measures bladder pressure. Urinalysis is to screen for bacteria. Results will be recorded and compared with previous study data.

    Time frame: on average, 30 minutes each visit completed 6 months, 1 year, and yearly

  3. Cardiovascular Assessment

    Participant blood pressure will be monitored over a 24-hour period outside the lab with a blood pressure monitor provided by the lab and during visit assessments. The reading will be recorded and compared to prior study readings.

    Time frame: 24 hours prior to visit, completed 6 months, 1 year, and yearly

Secondary outcomes

  1. Questionnaires

    All participants, regardless of prior training group will complete a series of questionnaires about their overall functioning at each follow-up visit. The questionnaires cover general topics about quality of life including perceived quality of life, experiences using the home stimulation program, and sexual (male or female), bladder and bowel function. These are multiple choice questions, with each answer valued between 0 and 5 points for all except the quality of life section, where answer scores vary based on question and has an overall score of 0-100. An aggregate score for each domain will be compiled and compared with recorded scores from before, during, and directly after the training portion of the study they previously completed as a secondary measure of comparison to the assessment results.

    Time frame: On average, 30 minutes each visit completed 6 months, 1 year, and yearly

  2. Imaging Assessments

    Participants may be asked to repeat imaging assessments that were performed during their previous intervention study such as a Dual-energy X-ray absorptiometry (DXA) and/or MRI. Imaging data will be compared to prior imaging to monitor for any changes.

    Time frame: On Average, 15 minutes each visit completed 6 months, 1 year, and yearly

  3. Spasticity Monitoring

    Each participant is assigned an observer to accompany the research participant on their visits. The responsibility of the observer is to communicate with the research participant and monitor their well-being. The observer, the technicians, the research nurse and/or the research physical therapist will monitor the research participant at each visit for spasticity events. If a participant experiences a spasticity event during any training, a member of the study team will visually monitor the spasm and record the duration, location, and level of pain the participant is experiencing.

    Time frame: Each visit completed 6 months, 1 year, and yearly

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — There is no plan to share individual participant data

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Jul 2028, 42 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 42 months is above that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2025
First posted
Jun 29, 2025
StartActual
Jan 13, 2025
Primary completionEst.
Jul 2028
CompletionEst.
Aug 2028
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and registry dates
1 update, last Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Minor edits only
    + 2 other changes: verification date and registry dates

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07042815
Lead sponsor
Kessler Foundation
Responsible party
Gail Forrest (Director, Tim and Caroline Reynolds Center for Spinal Stimulation, Kessler Foundation) — Principal investigator
First posted
Jun 29, 2025
Start date
Jan 13, 2025
Primary completion
Jul 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Nov 20, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion